Signal active
Bio
Casey Tansey joined USVP as a general partner in April 2005. A veteran of the medical device industry, Casey brings over 25 years of entrepreneurial, early-stage medical device and seasoned operating experience to USVP.
Casey's extensive operations experience brings more to the table than strategic counsel -- he adds empathy to that mix.
Casey's investment strategy is a lot like his strategy as a CEO: identify unmet clinical needs where patients are in need of new and improved products and services. At USVP, Casey focuses on the trend toward the miniaturization of devices and the development of minimally-invasive technologies that promise innovations in the delivery of medical products and services, especially in cardiovascular products, orthopedics, spinal care and neurology.
Casey's passion is to strive for delivery of medical services with less trauma to the patient and improved quality of life. Innovations shaping this trend include minimally-invasive technologies. During his tenure as CEO and President of Epicor Medical from 2001 to 2004, Casey, along with a dedicated team, pioneered a minimally-invasive treatment for atrial fibrillation and transformed the company into a recognized market leader, and he led Epicor's acquisition by St. Jude Medical.
Prior to Epicor, Casey was CEO and President of Heartport, a public company that helped pioneer minimally-invasive cardiac surgery which is now a Johnson & Johnson company. Before that, he was with Baxter Edward's Cardiovascular Division for nearly ten years, holding various sales and marketing positions. During his tenure at Baxter, Casey was involved in launching innovative heart valve products that have grown to be the market leaders.
Casey serves on the Board of Directors for ApniCure, CardioKinetix, Devax, Inspire Medical, Intersect ENT, Intuity Medical, ReShape Medical, and SentreHEART.
In addition, he served as the Chairman of the Board of Directors of the World Heart Foundation, an organization dedicated to advancing humanitarian efforts in heart surgery worldwide through education and collaboration.
Casey holds a B.S. and M.B.A. from the College of Notre Dame in Belmont, CA.
Casey has served on the boards of Epicor Medical and Heartport.
Location
Menlo Park, California, United States, North America
Social
N/A
Primary Organization
1981
577
175
158
11-50
Enterprise Software, Financial Services, Venture Capital
Jobs history
2
Luminopia
Board of Director
Invalid date - Current
MicroTransponder
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Casey Tansey is the General Partner at U.S. Venture Partners, based in United States, North America. With a background in Enterprise Software, Casey Tansey has a rich history of leadership and innovation. Casey Tansey studied BS unknown @ University of Notre Dame. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
14
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jun 01, 2021 | Standard Bariatrics | Series B - Standard Bariatrics | U.S. Venture Partners | 35.0M |
Jun 20, 2022 | MicroTransponder | Series E - MicroTransponder | U.S. Venture Partners | 73.0M |
Jun 27, 2023 | Luminopia | Series A - Luminopia | U.S. Venture Partners | 16.0M |
Feb 20, 2024 | Cagent Vascular | Series C - Cagent Vascular | U.S. Venture Partners | 30.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.